Skip to main content
. 2021 May 14;32(9):962–968. doi: 10.1097/CAD.0000000000001088

Table 2.

Demographics and characteristics of patients (N = 30)

Patient no Gender Age ECOG PS Histological type Stage Primary site Metastatic site Prior therapy Best response PFS (months)
1 Male 50 0 UPS IV Upper limb Lung Surgery, radiotherapy PR 21
2 Male 55 0 UPS IV Lower limb Lung Surgery, radiotherapy SD 8
3 Male 63 0 UPS IV Thoracic wall Lung Surgery PR 15
4 Female 45 1 UPS IV Lower limb Lung Surgery SD 12
5 Male 56 1 UPS IV Lower limb Lung Surgery, radiotherapy CR 21
6 Female 52 0 UPS IV Lower limb Lung Surgery SD 4
7 Male 58 0 UPS IV Paravertebral Lung Surgery, radiotherapy PR 16
8 Male 62 0 UPS IV Upper limb Lung Surgery, radiotherapy PD 2
9 Male 53 1 UPS IV Upper limb Lung Surgery PR 18
10 Male 40 0 Dedifferentiated liposarcoma IV Lower limb Lung Surgery, radiotherapy PR 10
11 Female 54 0 Dedifferentiated liposarcoma IIIB Upper limb Lymph Surgery, radiotherapy PD 2
12 Male 63 0 Dedifferentiated liposarcoma IV Lower limb Lung Surgery SD 3
13 Male 54 1 Dedifferentiated liposarcoma IV Lower limb Lung Surgery PD 2
14 Male 61 0 Dedifferentiated liposarcoma IV Lower limb Lung Surgery SD 4
15 Male 52 1 Dedifferentiated liposarcoma IV Pelvic girdle Lung Surgery SD 10
16 Female 65 1 Angiosarcoma IV Thoracic wall Lung Surgery PR 14
17 Male 64 0 Angiosarcoma IIIB Head and neck Lymph Surgery SD 7
18 Male 60 0 Angiosarcoma IV Lower limb Lung Surgery PD 2
19 Female 48 0 Leiomyosarcoma IV Lower limb Lung Surgery, radiotherapy PR 10
20 Male 26 1 Leiomyosarcoma IV Pelvic girdle Lung No SD 8
21 Female 48 0 Leiomyosarcoma IV Lower limb Lung Surgery SD 5
22 Female 48 1 Synovial sarcoma IV Pelvic girdle Lung Surgery PR 14
23 Female 40 0 Synovial sarcoma IV Pelvic girdle Lung Surgery, radiotherapy PR 9
24 Female 26 1 Synovial sarcoma IIIB Lower limb Lymph No PR 10
25 Male 20 1 Epithelioid sarcoma IIIB Lower limb Lymph No PD 2
26 Male 32 0 Epithelioid sarcoma IV Lower limb Lung, Lymph Surgery PD 2
27 Female 36 0 Myxofibrosarcoma IV Paravertebral Lung Surgery, radiotherapy SD 6
28 Female 42 0 Myxofibrosarcoma IV Paravertebral Lung No SD 8
29 Female 35 0 Clear cell sarcoma IV Lower limb Lung No SD 7
30 Male 55 0 Malignant peripheral nerve sheath tumor IV Upper limb Lung, lymph Surgery SD 4

CR, complete response; ECOG PS, Eastern Cooperative Oncology Group performance status; PD, progressive disease; PFS, progression-free survival; PR, partial response; SD, stable disease; UPS, undifferentiated pleomorphic sarcoma.